Stock Track | RIBOLIFE-B Soars 24.12% in Intraday Trading on Strong Hong Kong Debut

Stock Track01-09

RIBOLIFE-B (06938) surged 24.12% in intraday trading on Friday as the biotech startup made its highly anticipated debut on the Hong Kong Stock Exchange. The stock opened at HK$75 per share, significantly above its IPO price of HK$57.97, reflecting robust investor demand.

The company raised HK$1.7 billion from its IPO, with the Hong Kong public offer oversubscribed by 101.06 times and the international offering 16.7 times subscribed. Cornerstone investors, including major firms like China Asset Management, were allotted 42.5% of the global offering, underscoring strong institutional confidence in the company.

The market's enthusiastic response highlights investor optimism about Ribo Life Science's growth prospects in the biotech sector, driving the stock's sharp rise during its debut session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180247889?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-09 09:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180247889","market":"us","top_or_hot":-1,"title":"Stock Track | RIBOLIFE-B Soars 24.12% in Intraday Trading on Strong Hong Kong Debut","media":"Stock Track","content":"<p>RIBOLIFE-B (06938) surged 24.12% in intraday trading on Friday as the biotech startup made its highly anticipated debut on the Hong Kong Stock Exchange. The stock opened at HK$75 per share, significantly above its IPO price of HK$57.97, reflecting robust investor demand.</p><p>The company raised HK$1.7 billion from its IPO, with the Hong Kong public offer oversubscribed by 101.06 times and the international offering 16.7 times subscribed. Cornerstone investors, including major firms like China Asset Management, were allotted 42.5% of the global offering, underscoring strong institutional confidence in the company.</p><p>The market's enthusiastic response highlights investor optimism about Ribo Life Science's growth prospects in the biotech sector, driving the stock's sharp rise during its debut session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | RIBOLIFE-B Soars 24.12% in Intraday Trading on Strong Hong Kong Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | RIBOLIFE-B Soars 24.12% in Intraday Trading on Strong Hong Kong Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-09 09:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>RIBOLIFE-B (06938) surged 24.12% in intraday trading on Friday as the biotech startup made its highly anticipated debut on the Hong Kong Stock Exchange. The stock opened at HK$75 per share, significantly above its IPO price of HK$57.97, reflecting robust investor demand.</p><p>The company raised HK$1.7 billion from its IPO, with the Hong Kong public offer oversubscribed by 101.06 times and the international offering 16.7 times subscribed. Cornerstone investors, including major firms like China Asset Management, were allotted 42.5% of the global offering, underscoring strong institutional confidence in the company.</p><p>The market's enthusiastic response highlights investor optimism about Ribo Life Science's growth prospects in the biotech sector, driving the stock's sharp rise during its debut session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06938","symbol_name":"瑞博生物-B","start_time":0,"source_url":"","article_id":"1180247889","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180247889","pubTimestamp":1767922349,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"RIBOLIFE-B (06938) surged 24.12% in intraday trading on Friday as the biotech startup made its highly anticipated debut on the Hong Kong Stock Exchange. The stock opened at HK$75 per share,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06938":"瑞博生物-B"},"translate_title":"个股赛道|RIBOLIFE-B强势港股首秀盘中大涨24.12%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06938":1},"content_text":"RIBOLIFE-B (06938) surged 24.12% in intraday trading on Friday as the biotech startup made its highly anticipated debut on the Hong Kong Stock Exchange. The stock opened at HK$75 per share, significantly above its IPO price of HK$57.97, reflecting robust investor demand.The company raised HK$1.7 billion from its IPO, with the Hong Kong public offer oversubscribed by 101.06 times and the international offering 16.7 times subscribed. Cornerstone investors, including major firms like China Asset Management, were allotted 42.5% of the global offering, underscoring strong institutional confidence in the company.The market's enthusiastic response highlights investor optimism about Ribo Life Science's growth prospects in the biotech sector, driving the stock's sharp rise during its debut session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180247889","isCrawlerRequest":true}